The North America Sequencing Reagents Market is expected to witness market growth of 16.9% CAGR during the forecast period (2024-2031).
The US market dominated the North America Sequencing Reagents Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $7.55 billion by 2031. Canada market is experiencing a CAGR of 19.2% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 18.4% during 2024-2031.
Beyond healthcare, sequencing technologies have revolutionized agriculture, environmental sciences, and evolutionary biology research. In agriculture, genomic sequencing has enabled the identification of genes linked to desirable traits such as drought resistance, pest tolerance, and higher yields.
Additionally, drought-resistant rice varieties and pest-resistant maize and wheat strains have been developed using insights from sequencing, contributing to sustainable farming and addressing food security challenges exacerbated by climate change. These advancements rely on sequencing reagents to ensure the precision and reliability of genetic data, which is crucial for breeding programs and genetic engineering efforts.
Oncology is a significant application of sequencing technologies across North America, driving substantial reagent demand. In the U.S., initiatives like the Cancer Moonshot have allocated billions of dollars to accelerate cancer research, emphasizing the role of genomic sequencing in understanding tumor biology and guiding targeted therapies. Canada’s investments in cancer genomics, such as through the Ontario Institute for Cancer Research, support advanced studies in identifying biomarkers and genetic predispositions. In Mexico, oncology research has begun to adopt genomic sequencing to address increasing cancer rates, focusing on early diagnosis and precision treatment. These efforts highlight sequencing reagents' critical role in enabling accurate and reliable results in cancer research and treatment across the region.
The US market dominated the North America Sequencing Reagents Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $7.55 billion by 2031. Canada market is experiencing a CAGR of 19.2% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 18.4% during 2024-2031.
Beyond healthcare, sequencing technologies have revolutionized agriculture, environmental sciences, and evolutionary biology research. In agriculture, genomic sequencing has enabled the identification of genes linked to desirable traits such as drought resistance, pest tolerance, and higher yields.
Additionally, drought-resistant rice varieties and pest-resistant maize and wheat strains have been developed using insights from sequencing, contributing to sustainable farming and addressing food security challenges exacerbated by climate change. These advancements rely on sequencing reagents to ensure the precision and reliability of genetic data, which is crucial for breeding programs and genetic engineering efforts.
Oncology is a significant application of sequencing technologies across North America, driving substantial reagent demand. In the U.S., initiatives like the Cancer Moonshot have allocated billions of dollars to accelerate cancer research, emphasizing the role of genomic sequencing in understanding tumor biology and guiding targeted therapies. Canada’s investments in cancer genomics, such as through the Ontario Institute for Cancer Research, support advanced studies in identifying biomarkers and genetic predispositions. In Mexico, oncology research has begun to adopt genomic sequencing to address increasing cancer rates, focusing on early diagnosis and precision treatment. These efforts highlight sequencing reagents' critical role in enabling accurate and reliable results in cancer research and treatment across the region.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.Illumina, Inc.
Market Report Segmentation
By Type
- Sequencing Kits
- Library Kits
- Control Kits
- Template Kits
- Other Type
By Technology
- Next-Generation Sequencing
- Third Generation Sequencing
- Sanger Sequencing
By Application
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- Consumer Genomics
- Other Application
By End Use
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Use
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Sequencing Reagents Market by Type
Chapter 6. North America Sequencing Reagents Market by Technology
Chapter 7. North America Sequencing Reagents Market by Application
Chapter 8. North America Sequencing Reagents Market by End Use
Chapter 9. North America Sequencing Reagents Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
- Illumina, Inc.
Methodology
LOADING...
